These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 32378801)

  • 1. Comprehensive overview of COVID-19 based on current evidence.
    Kang Y; Xu S
    Dermatol Ther; 2020 Sep; 33(5):e13525. PubMed ID: 32378801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.
    Hon KL; Leung KKY; Leung AKC; Sridhar S; Qian S; Lee SL; Colin AA
    Pediatr Pulmonol; 2020 Jul; 55(7):1584-1591. PubMed ID: 32483934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.
    Guo YR; Cao QD; Hong ZS; Tan YY; Chen SD; Jin HJ; Tan KS; Wang DY; Yan Y
    Mil Med Res; 2020 Mar; 7(1):11. PubMed ID: 32169119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing the identification effectiveness of an unknown outbreak of the Infectious Diseases Seeker (IDS) using and comparing the novel coronavirus disease (COVID-19) outbreak with the past SARS and MERS epidemics.
    Baldassi F; Cenciarelli O; Malizia A; Gaudio P
    J Infect Public Health; 2021 Jan; 14(1):123-130. PubMed ID: 33412372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
    Bchetnia M; Girard C; Duchaine C; Laprise C
    J Infect Public Health; 2020 Nov; 13(11):1601-1610. PubMed ID: 32778421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus Disease 2019: Coronaviruses and Blood Safety.
    Chang L; Yan Y; Wang L
    Transfus Med Rev; 2020 Apr; 34(2):75-80. PubMed ID: 32107119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us.
    Kumar V
    Int Rev Immunol; 2021; 40(1-2):5-53. PubMed ID: 32744465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.
    Lai CC; Shih TP; Ko WC; Tang HJ; Hsueh PR
    Int J Antimicrob Agents; 2020 Mar; 55(3):105924. PubMed ID: 32081636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
    Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S
    Front Immunol; 2020; 11():1949. PubMed ID: 32849654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia.
    Barry M; Al Amri M; Memish ZA
    J Epidemiol Glob Health; 2020 Mar; 10(1):1-3. PubMed ID: 32175703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.
    Lin L; Lu L; Cao W; Li T
    Emerg Microbes Infect; 2020 Dec; 9(1):727-732. PubMed ID: 32196410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.
    Gulati A; Pomeranz C; Qamar Z; Thomas S; Frisch D; George G; Summer R; DeSimone J; Sundaram B
    Am J Med Sci; 2020 Jul; 360(1):5-34. PubMed ID: 32620220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
    Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
    Front Immunol; 2020; 11():1880. PubMed ID: 32973779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?
    Peeri NC; Shrestha N; Rahman MS; Zaki R; Tan Z; Bibi S; Baghbanzadeh M; Aghamohammadi N; Zhang W; Haque U
    Int J Epidemiol; 2020 Jun; 49(3):717-726. PubMed ID: 32086938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.
    Wu Z; Harrich D; Li Z; Hu D; Li D
    Rev Med Virol; 2021 Mar; 31(2):e2171. PubMed ID: 33350025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV.
    Xu J; Zhao S; Teng T; Abdalla AE; Zhu W; Xie L; Wang Y; Guo X
    Viruses; 2020 Feb; 12(2):. PubMed ID: 32098422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human coronaviruses (HCoVs) and the molecular mechanisms of SARS-CoV-2 infection.
    Santacroce L; Charitos IA; Carretta DM; De Nitto E; Lovero R
    J Mol Med (Berl); 2021 Jan; 99(1):93-106. PubMed ID: 33269412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
    Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH
    Front Immunol; 2020; 11():1022. PubMed ID: 32574260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.